According to a person familiar with the matter, recently, the pharmaceutical administration department of the national health and health commission drafted the "opinions on further improving the national basic drug system", which is currently in the discussion and consultation process of relevant units. The deadline for feedback is 12 o 'clock on August 3.

 

According to the draft of the opinions, the content of the improvement mainly includes the dynamic adjustment and optimization of the catalogue, the effective guarantee of production supply, the preferential use of comprehensive equipment, the reduction of the burden of people's pharmaceutical expenses, and the improvement of the quality and safety level.

 

▍ once every three years to adjust the directory

 

According to the draft of the opinions, the management mechanism of the catalogue of essential drugs will be improved. Optimize the selection and adjustment procedures for the catalogue, in principle, once every three years.

 

As for the adjustment of the basic medicine catalogue, it is natural for everyone to think of expansion, which is also the feature of the catalogue from 2009 edition to 2012 edition and 2017 edition.

 

In fact, when it comes to adjustment, there must be a call in and a call out. According to the draft, priority should be given to drugs such as generic drug consistency evaluation and significant cost-benefit ratio, with emphasis on drugs with serious adverse reactions and which can be replaced by more cost-effective varieties.

 

Previously, according to a person familiar with the matter, the relevant departments organized an internal study on the adjustment of the basic medicine catalogue, which covered digestion, respiration, infection, nerve, cardiovascular system, endocrine system, tumor, blood, pediatrics and other categories. These categories are likely to be the focus of the expansion.

 

Today, though, policies such as the integration of the two guarantees, graded diagnosis and treatment, and the use of a certain proportion of non-base drugs in grass-roots equipment may weaken the role of the base medicine inventory. But, you know, the key to graded care is primary care. Being able to enter the catalog of essential medicines means being qualified for grassroots marketing, which will hopefully drive the sales of products.

 

▍ reimbursement ratio, higher than the base

 

The draft also mentioned that basic drugs for clinical diagnosis and treatment were included in the reimbursement list of basic medical insurance drugs after the procedures of the medical insurance department, and the reimbursement ratio was significantly higher than that of non-basic drugs. In addition, some basic drugs are provided free of charge to patients with hypertension, diabetes and serious mental disorders through the means of full financial security or full reimbursement of medical insurance.

 

China's basic drug system has been in operation for nine years since it was established in 2009. In recent years, anhui, guangdong, guangxi and other parts of the country have first tried to meet the needs of some people with chronic diseases by providing basic drugs as public goods free of charge to residents in the form of full guarantee, so as to truly realize the fair access to basic drugs and enjoy them for all.

 

According to relevant statistics, more than 70 percent of drugs in developed countries are funded by public institutions through reimbursement schemes and other mechanisms. Australia's drug insurance subsidy system, for example, covers 90% of the drug market.

 

In the last two years, many people believe that the basic medicine catalog in the pharmaceutical market seems less important than before. And for products that don't necessarily require a generic identity, being safe in the health insurance catalog is king.

 

In addition, most people believe that it is no longer mandatory for basic drugs, and that a certain proportion of non-basic drugs will be provided at the grassroots level, which will overturn the competition pattern of medical institutions at all levels in the past.

 

In my opinion, once the reimbursement ratio of basic drugs is higher than that of non-basic drugs, and some basic drugs are provided free of charge nationwide, the promotion of this series of measures will bring greater impact and influence to the current medical market pattern.

 

At that time, you will also feel that the base medicine directory is not important?